Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 29, Issue 10, Pages 1119-1128
Publisher
SAGE Publications
Online
2015-08-13
DOI
10.1177/0269881115599385
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties
- (2014) B Guardiola-Lemaitre et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antidepressants and Sexual Dysfunction: Mechanisms and Clinical Implications
- (2014) Anita H. Clayton et al. POSTGRADUATE MEDICINE
- Antidepressant drugs and sexual dysfunction
- (2013) David S. Baldwin et al. BRITISH JOURNAL OF PSYCHIATRY
- Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis
- (2013) Ursula Reichenpfader et al. DRUG SAFETY
- Antidepressant-induced sexual dysfunction in men
- (2013) Robert Taylor Segraves et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release?
- (2013) Elisabeth Y. Bijlsma et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Female Sexual Dysfunction in Patients Treated with Antidepressant—Comparison between Escitalopram and Fluoxetine
- (2011) Hatta Sidi et al. Journal of Sexual Medicine
- The Effect of Major Depression on Sexual Function in Women
- (2011) Louis F. Fabre et al. Journal of Sexual Medicine
- Neural Correlates of Antidepressant-Related Sexual Dysfunction: A Placebo-Controlled fMRI Study on Healthy Males Under Subchronic Paroxetine and Bupropion
- (2011) Birgit Abler et al. NEUROPSYCHOPHARMACOLOGY
- Escitalopram
- (2010) Karly P. Garnock-Jones et al. CNS DRUGS
- Agomelatine in the Treatment of Major Depressive Disorder
- (2010) Sidney H. Kennedy et al. CNS DRUGS
- Psychometric Properties of the Spanish Version of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) in Patients with Severe Mental Disorders
- (2010) Maria Paz Garcia-Portilla et al. Journal of Sexual Medicine
- Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting
- (2010) Kyoung-Uk Lee et al. Psychiatry Investigation
- Treatment-Emergent Sexual Dysfunction Related to Antidepressants
- (2009) Alessandro Serretti et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey
- (2009) VSL Williams et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR
- (2008) Sidney H. Kennedy et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale
- (2008) AL Montejo et al. JOURNAL OF PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now